Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: AMGN PFE LLY MRK REGN JNJ BMY VRTX GILD BIIB

| Held by: IJH VTI VB VBR XMHQ VXF MDY IBB XBI IJK

Index	-	P/E	18.17	EPS (ttm)	26.39	Insider Own	3.54%	Shs Outstand	42.90M	Perf Week	-0.09%
Market Cap	20.65B	Forward P/E	15.79	EPS next Y	30.36	Insider Trans	-35.41%	Shs Float	41.53M	Perf Month	5.62%
Enterprise Value	17.88B	PEG	1.98	EPS next Q	7.10	Inst Own	96.11%	Short Float	3.97%	Perf Quarter	18.75%
Income	1.27B	P/S	6.60	EPS this Y	11.61%	Inst Trans	-5.54%	Short Ratio	2.59	Perf Half Y	46.01%
Sales	3.13B	P/B	3.12	EPS next Y	10.42%	ROA	17.57%	Short Interest	1.65M	Perf YTD	35.90%
Book/sh	153.61	P/C	7.46	EPS next 5Y	9.20%	ROE	20.04%	52W High	492.62 -2.66%	Perf Year	28.07%
Cash/sh	64.28	P/FCF	18.40	EPS past 3/5Y	34.80% -	ROIC	19.30%	52W Low	266.98 79.61%	Perf 3Y	73.98%
Dividend Est.	-	EV/EBITDA	11.18	Sales past 3/5Y	19.52% 14.71%	Gross Margin	88.59%	Volatility	2.08% 2.39%	Perf 5Y	261.92%
Dividend TTM	-	EV/Sales	5.71	EPS Y/Y TTM	17.16%	Oper. Margin	48.46%	ATR (14)	11.77	Perf 10Y	214.16%
Dividend Ex-Date	-	Quick Ratio	6.07	Sales Y/Y TTM	13.50%	Profit Margin	40.65%	RSI (14)	58.54	Recom	1.69
Dividend Gr. 3/5Y	- -	Current Ratio	6.40	EPS Q/Q	12.12%	SMA20	0.91%	Beta	0.84	Target Price	526.09
Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	6.76%	SMA50	5.92%	Rel Volume	0.74	Prev Close	489.31
Employees	1305	LT Debt/Eq	0.00	Earnings	Oct 29 BMO	SMA200	36.86%	Avg Volume	636.40K	Price	479.51
IPO	Jun 17, 1999	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.14% -1.64%	Trades		Volume	467,795	Change	-2.00%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-20-25	Initiated	Wells Fargo	Underweight	$414
Sep-26-25	Initiated	RBC Capital Mkts	Outperform	$569
Jun-02-25	Initiated	Cantor Fitzgerald	Overweight	$405
Apr-25-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-21-25	Upgrade	BofA Securities	Underperform → Neutral	$314
Jul-11-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$310 → $321
Feb-12-24	Upgrade	Goldman	Sell → Neutral	$213 → $215
Feb-05-24	Initiated	Leerink Partners	Outperform	$330
Dec-08-23	Initiated	Wells Fargo	Overweight	$309
Dec-06-22	Initiated	UBS	Buy	$320
Dec-05-22	Initiated	Goldman	Sell	$230
Oct-11-22	Initiated	Morgan Stanley	Overweight	$288
Sep-20-22	Reiterated	BofA Securities	Underperform
Sep-19-22	Resumed	Wedbush	Outperform	$263
Feb-11-22	Initiated	BTIG Research	Neutral
Jul-14-21	Upgrade	Argus	Hold → Buy	$205
Apr-26-21	Resumed	Credit Suisse	Outperform	$196
Feb-01-21	Upgrade	H.C. Wainwright	Neutral → Buy	$125 → $195
Sep-14-20	Resumed	JP Morgan	Overweight	$142
Jun-25-20	Reiterated	H.C. Wainwright	Neutral	$85 → $125

Show Previous Ratings

Dec-05-25 11:30AM	Catalyst (CPRX) Up 10% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-04-25 11:30AM	Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue? (Zacks)
11:20AM	Can Merck's New Products Aid Growth as Keytruda LOE Test Looms? (Zacks)
Dec-03-25 07:19AM	Flurry of Bullish Inflows Sends United Therapeutics Higher (FX Empire)
Nov-21-25 12:04PM	United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base (Investor's Business Daily)
09:40AM	Loading…
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Nov-20-25 09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
Nov-19-25 10:52AM	Merck Stock Rise as New PAH Drug Winrevair Meets Goal in Another Study (Zacks)
Nov-12-25 09:50AM	Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-09-25 11:02PM	3 Reasons Investors Love United Therapeutics (UTHR) (StockStory)
Nov-05-25 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
12:35AM	The 5 Most Interesting Analyst Questions From United Therapeutics's Q3 Earnings Call (StockStory)
Nov-04-25 09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
07:00AM	United Therapeutics Corporation to Present at Upcoming Investor Conferences (Business Wire)
Nov-03-25 07:00AM	United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease (Business Wire)
03:48PM	Loading…
Oct-30-25 03:48PM	United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
11:40AM	MKKGY vs. UTHR: Which Stock Is the Better Value Option? (Zacks)
01:38AM	UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook (StockStory)
Oct-29-25 04:14PM	United Therapeutics Rockets 10% On Growing Enthusiasm For Its Top Drug (Investor's Business Daily) +9.63%
01:11PM	Why Is United Therapeutics (UTHR) Stock Soaring Today (StockStory)
11:24AM	United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark (Zacks)
09:55AM	The Mixed Results For United Therapeutics' Bread-And-Butter Drug (Investor's Business Daily)
09:30AM	Compared to Estimates, United Therapeutics (UTHR) Q3 Earnings: A Look at Key Metrics (Zacks)
08:51AM	United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short (Investor's Business Daily)
07:40AM	United Therapeutics (UTHR) Beats Q3 Earnings Estimates (Zacks)
06:48AM	United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
06:43AM	United Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results (Business Wire)
Oct-27-25 11:17PM	United Therapeutics (UTHR) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-24-25 10:05AM	Merck's Non-Oncology Drugs Q3 Performance: What to Expect (Zacks)
10:00AM	Loading…
Oct-23-25 10:00AM	Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-22-25 10:00AM	United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-16-25 03:51PM	Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case (Insider Monkey)
Oct-15-25 07:00AM	United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025 (Business Wire)
Oct-13-25 07:00AM	United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting (Business Wire)
Oct-01-25 10:40AM	Is IPF the Next Big Market Opportunity for United Therapeutics? (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Sep-30-25 04:38PM	Top Stock Reports for NextEra Energy, U.S. Bancorp and Air Products & Chemicals (Zacks)
Sep-26-25 09:46AM	CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls (The Fly)
Sep-19-25 11:53AM	Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE? (Zacks)
07:00AM	United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso in Idiopathic Pulmonary Fibrosis (Business Wire)
12:46AM	1 Momentum Stock to Target This Week and 2 We Brush Off (StockStory)
12:03AM	3 Big Reasons to Love United Therapeutics (UTHR) (StockStory)
Sep-16-25 07:00AM	United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum (Business Wire)
Sep-12-25 07:00AM	United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress (Business Wire)
Sep-11-25 11:30AM	Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue? (Zacks)
Sep-10-25 02:46PM	United Therapeutics Price Strength Rating Jumps; Stock Soared 33% Last Week (Investor's Business Daily)
Sep-03-25 01:48PM	UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals (Zacks)
09:00AM	Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint (TipRanks)
08:52AM	Pharma, Opendoor, Tesla: Trending Stocks (Yahoo Finance Video)
06:30AM	Lung Disease Breakthrough Boosts United Therapeutics and its Rivals (The Daily Upside)
Sep-02-25 04:09PM	Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It (Investor's Business Daily) +32.83%
09:34AM	Why United Therapeutics Just Catapulted 35%, Pulling Insmed, Liquidia With It (Investor's Business Daily)
07:00AM	United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis (Business Wire)
Aug-29-25 11:30AM	Why Is United Therapeutics (UTHR) Up 11.9% Since Last Earnings Report? (Zacks)
07:00AM	United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference (Business Wire)
Aug-13-25 12:05AM	5 Insightful Analyst Questions From United Therapeutics's Q2 Earnings Call (StockStory)
Aug-12-25 11:40PM	UTHR Q2 Deep Dive: Tyvaso DPI Drives Growth Amid Pipeline and Competitive Uncertainty (StockStory)
04:06PM	Liquidia Shoots Higher As Yutrepia Launch Kicks Off Amid United Patent Battle (Investor's Business Daily)
10:00AM	Liquidia Shoots Higher, But At-Risk Launch Could Come Back To Haunt It (Investor's Business Daily)
Aug-11-25 04:15PM	3D Systems Reports Second Quarter 2025 Financial Results (GlobeNewswire)
11:32AM	Merck's Narrowed 2025 Sales View: What it Means After Q2 Results? (Zacks)
Aug-01-25 07:00AM	United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program (Business Wire) +7.13%
Jul-31-25 10:15AM	UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y (Zacks)
Jul-30-25 09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks) -5.25%
09:30AM	Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key Metrics (Zacks)
07:35AM	United Therapeutics (UTHR) Misses Q2 Earnings Estimates (Zacks)
06:46AM	United Therapeutics (NASDAQ:UTHR) Misses Q2 Revenue Estimates (StockStory)
06:36AM	United Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results (Business Wire)
Jul-28-25 11:13PM	What To Expect From United Therapeutics's (UTHR) Q2 Earnings (StockStory)
10:00AM	Earnings Preview: Ardelyx (ARDX) Q2 Earnings Expected to Decline (Zacks)
02:07AM	Leerink Partners Remains a Buy on United Therapeutics Corporation (UTHR) With a $408 PT (Insider Monkey)
Jul-25-25 10:42PM	United Therapeutics Corporation (UTHR) Launches First UKidney Human Trial (Insider Monkey)
Jul-24-25 09:50AM	United Therapeutics (UTHR) Crossed Above the 50-Day Moving Average: What That Means for Investors (Zacks)
08:00AM	Insmed Is Trading At A 25-Year High. Will Its 'Skeleton Key' Work? (Investor's Business Daily)
Jul-23-25 10:00AM	United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy? (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jul-21-25 06:32PM	United Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag (Insider Monkey)
Jul-18-25 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
Jul-16-25 07:00AM	United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025 (Business Wire)
Jul-15-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:59AM	Liquidia Receives $50M from HCRx, Accelerates YUTREPIA's Commercial Launch Following Favorable Court Ruling (Insider Monkey)
Jul-11-25 09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
Jul-10-25 11:26PM	UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR) (Insider Monkey)
Jul-09-25 12:33AM	1 Value Stock with Impressive Fundamentals and 2 to Turn Down (StockStory)
Jul-07-25 08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jul-04-25 12:10PM	Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-03-25 08:30AM	MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE (Zacks)
Jul-02-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jun-28-25 04:16AM	United Therapeutics Announces World's First Bioengineered External Liver Treatment in Clinical Study (Insider Monkey)
Jun-26-25 09:40AM	Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term (Zacks)
Jun-25-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
07:40AM	5 Must-Read Analyst Questions From United Therapeutics's Q1 Earnings Call (StockStory)
Jun-24-25 12:20PM	MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal (Zacks)
07:00AM	United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver (Business Wire)
Jun-23-25 07:00AM	United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension (Business Wire)
Jun-13-25 02:32AM	United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock? (Zacks)
Jun-11-25 11:04AM	Insmed Stock Jumps 29% on Encouraging PAH Study Results (Zacks)

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 03 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 05 04:54 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 04 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 05 04:54 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 04 '25	Sale	480.01	4,000	1,920,043	130	Dec 05 04:54 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 03 '25	Sale	475.27	4,000	1,901,087	130	Dec 05 04:54 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 05 '25	Proposed Sale	483.28	4,000	1,933,120		Dec 05 04:18 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 04 '25	Proposed Sale	480.01	4,000	1,920,043		Dec 04 03:30 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 03 '25	Proposed Sale	475.27	4,000	1,901,088		Dec 03 03:21 PM
EDGEMOND JAMES	CFO AND TREASURER	Dec 01 '25	Option Exercise	146.03	21,000	3,066,630	29,142	Dec 02 04:32 PM
EDGEMOND JAMES	CFO AND TREASURER	Dec 01 '25	Sale	479.99	21,000	10,079,696	8,142	Dec 02 04:32 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 01 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 02 04:32 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 02 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 02 04:32 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 01 '25	Sale	481.93	4,000	1,927,703	130	Dec 02 04:32 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 02 '25	Sale	481.29	4,000	1,925,143	130	Dec 02 04:32 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 01 '25	Option Exercise	127.65	22,500	2,872,226	14,625	Dec 02 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 01 '25	Sale	479.91	22,500	10,798,079	0	Dec 02 04:31 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 02 '25	Proposed Sale	481.29	4,000	1,925,143		Dec 02 03:58 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 01 '25	Proposed Sale	481.93	4,000	1,927,703		Dec 01 04:49 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 26 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 01 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 28 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 01 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 28 '25	Sale	487.64	4,000	1,950,550	130	Dec 01 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 26 '25	Sale	485.05	4,000	1,940,204	130	Dec 01 04:31 PM
JAMES EDGEMOND	Officer	Dec 01 '25	Proposed Sale	486.00	105,000	51,030,000		Dec 01 04:23 PM
Michael Benkowitz	Officer	Dec 01 '25	Proposed Sale	486.00	112,500	54,675,000		Dec 01 04:19 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 28 '25	Proposed Sale	487.64	4,000	1,950,550		Nov 28 04:08 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 24 '25	Option Exercise	146.03	21,000	3,066,630	29,142	Nov 26 04:31 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 24 '25	Sale	473.64	21,000	9,946,544	8,142	Nov 26 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 24 '25	Option Exercise	137.07	22,500	3,084,146	12,000	Nov 26 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 24 '25	Sale	473.66	22,500	10,657,280	0	Nov 26 04:30 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Nov 26 '25	Option Exercise	135.42	11,000	1,489,620	47,781	Nov 26 04:30 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Nov 26 '25	Sale	486.06	11,000	5,346,701	36,781	Nov 26 04:30 PM
PAUL MAHON	Officer	Nov 26 '25	Proposed Sale	486.06	11,000	5,346,701		Nov 26 04:04 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 26 '25	Proposed Sale	485.05	4,000	1,940,204		Nov 26 03:45 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 24 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 25 04:49 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 25 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 25 04:49 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 25 '25	Sale	475.33	4,000	1,901,305	130	Nov 25 04:49 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 24 '25	Sale	470.78	4,000	1,883,114	130	Nov 25 04:49 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 25 '25	Proposed Sale	475.33	4,000	1,901,305		Nov 25 03:04 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 24 '25	Proposed Sale	470.78	4,000	1,883,114		Nov 24 03:46 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 20 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 21 05:26 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 21 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 21 05:26 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 20 '25	Sale	478.38	4,000	1,913,524	130	Nov 21 05:26 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 21 '25	Sale	474.64	4,000	1,898,558	130	Nov 21 05:26 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 21 '25	Proposed Sale	474.64	4,000	1,898,558		Nov 21 03:59 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 18 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 20 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 19 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 20 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 19 '25	Sale	474.58	4,000	1,898,336	130	Nov 20 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 18 '25	Sale	472.76	4,000	1,891,037	130	Nov 20 04:31 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 20 '25	Proposed Sale	478.38	4,000	1,913,524		Nov 20 03:00 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 19 '25	Proposed Sale	474.58	4,000	1,898,336		Nov 19 02:40 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 17 '25	Option Exercise	139.13	22,500	3,130,504	14,625	Nov 18 04:36 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 17 '25	Sale	470.43	22,500	10,584,756	0	Nov 18 04:36 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 17 '25	Option Exercise	146.03	21,000	3,066,630	18,806	Nov 18 04:35 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 17 '25	Sale	470.36	21,000	9,877,535	8,118	Nov 18 04:35 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 14 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 18 04:35 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 17 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 18 04:35 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 17 '25	Sale	467.55	4,000	1,870,192	130	Nov 18 04:35 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 14 '25	Sale	462.94	4,000	1,851,774	130	Nov 18 04:35 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 18 '25	Proposed Sale	472.76	4,000	1,891,038		Nov 18 04:00 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 17 '25	Proposed Sale	467.55	4,000	1,870,192		Nov 17 04:10 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 14 '25	Proposed Sale	462.94	4,000	1,851,774		Nov 14 03:00 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 12 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 13 06:32 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 13 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 13 06:32 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 13 '25	Sale	728.96	4,000	2,915,859	130	Nov 13 06:32 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 12 '25	Sale	460.00	4,000	1,839,996	130	Nov 13 06:32 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 13 '25	Proposed Sale	463.35	4,000	1,853,409		Nov 13 04:37 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Nov 13 '25	Option Exercise	135.42	11,000	1,489,620	47,781	Nov 13 04:33 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Nov 13 '25	Sale	464.76	11,000	5,112,335	36,781	Nov 13 04:33 PM
PAUL MAHON	Officer	Nov 13 '25	Proposed Sale	464.76	11,000	5,112,335		Nov 13 04:04 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 10 '25	Option Exercise	146.03	7,875	1,149,986	7,875	Nov 12 05:14 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 10 '25	Sale	452.07	22,500	10,171,683	0	Nov 12 05:14 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 10 '25	Option Exercise	146.03	21,000	3,066,630	29,118	Nov 12 05:13 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 10 '25	Sale	452.07	21,000	9,493,483	8,118	Nov 12 05:13 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 10 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 12 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 11 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 12 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 11 '25	Sale	451.82	4,000	1,807,283	130	Nov 12 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 10 '25	Sale	448.39	4,000	1,793,546	130	Nov 12 04:31 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 11 '25	Proposed Sale	451.82	4,000	1,807,283		Nov 12 03:15 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 10 '25	Proposed Sale	448.39	4,000	1,793,546		Nov 10 04:37 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 06 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 07 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 06 '25	Sale	448.58	4,000	1,794,308	130	Nov 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 07 '25	Sale	448.25	4,000	1,793,008	130	Nov 07 04:30 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 07 '25	Proposed Sale	448.25	4,000	1,793,008		Nov 07 04:23 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 04 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 06 04:33 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 05 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 06 04:33 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 05 '25	Sale	437.98	4,000	1,751,922	130	Nov 06 04:33 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 04 '25	Sale	434.13	4,000	1,736,501	130	Nov 06 04:33 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 06 '25	Proposed Sale	448.58	4,000	1,794,308		Nov 06 04:27 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 05 '25	Proposed Sale	437.98	4,000	1,751,922		Nov 05 04:43 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 04 '25	Option Exercise	146.03	21,000	3,066,630	29,118	Nov 05 04:31 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 04 '25	Sale	436.09	21,000	9,157,821	8,118	Nov 05 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 31 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 04 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 03 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 04 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 31 '25	Sale	450.35	4,000	1,801,398	130	Nov 04 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 03 '25	Sale	438.30	4,000	1,753,194	130	Nov 04 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 03 '25	Option Exercise	139.13	22,500	3,130,504	14,625	Nov 04 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 03 '25	Sale	429.25	22,500	9,658,073	0	Nov 04 04:30 PM
JAMES C EDGEMOND	Officer	Nov 04 '25	Proposed Sale	438.66	84,000	36,847,440		Nov 04 04:29 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 04 '25	Proposed Sale	434.13	4,000	1,736,501		Nov 04 04:24 PM
Michael Benkowitz	Officer	Nov 03 '25	Proposed Sale	445.43	90,000	40,088,700		Nov 03 04:23 PM

Open in Screener

ARES

Ares Management Corp

Dec 08 • 04:00PM ET

164.26

-1.20 -0.73 %

Financial • Asset Management • USA • NYSE

ARES Ares Management Corp daily Stock Chart

Peers: BX APO KKR CG BAM WELL BXMT MC HLNE KYN

| Held by: VTI VO VUG VXF VOT IWP IWF IWR VYM DGRO

Index	-	P/E	69.98	EPS (ttm)	2.35	Insider Own	5.87%	Shs Outstand	216.83M	Perf Week	2.98%
Market Cap	53.69B	Forward P/E	25.16	EPS next Y	6.53	Insider Trans	-51.27%	Shs Float	207.70M	Perf Month	8.59%
Enterprise Value	69.08B	PEG	2.78	EPS next Q	1.71	Inst Own	88.74%	Short Float	2.97%	Perf Quarter	-6.17%
Income	511.84M	P/S	8.83	EPS this Y	27.36%	Inst Trans	-0.11%	Short Ratio	3.24	Perf Half Y	-4.67%
Sales	6.08B	P/B	8.09	EPS next Y	29.10%	ROA	2.37%	Short Interest	6.17M	Perf YTD	-7.21%
Book/sh	20.31	P/C	35.80	EPS next 5Y	25.16%	ROE	18.64%	52W High	200.49 -18.07%	Perf Year	-7.12%
Cash/sh	4.59	P/FCF	19.00	EPS past 3/5Y	-1.20% 14.31%	ROIC	2.98%	52W Low	110.63 48.48%	Perf 3Y	111.53%
Dividend Est.	4.51 (2.75%)	EV/EBITDA	36.04	Sales past 3/5Y	-0.73% 18.68%	Gross Margin	78.15%	Volatility	2.72% 3.23%	Perf 5Y	264.81%
Dividend TTM	4.29 (2.61%)	EV/Sales	11.37	EPS Y/Y TTM	7.32%	Oper. Margin	27.99%	ATR (14)	4.80	Perf 10Y	1089.31%
Dividend Ex-Date	Dec 17, 2025	Quick Ratio	0.50	Sales Y/Y TTM	50.70%	Profit Margin	8.42%	RSI (14)	66.96	Recom	1.82
Dividend Gr. 3/5Y	25.54% 23.78%	Current Ratio	0.50	EPS Q/Q	108.71%	SMA20	7.15%	Beta	1.54	Target Price	184.86
Payout	179.61%	Debt/Eq	2.84	Sales Q/Q	70.35%	SMA50	8.49%	Rel Volume	1.13	Prev Close	165.46
Employees	3200	LT Debt/Eq	2.84	Earnings	Nov 03 BMO	SMA200	0.80%	Avg Volume	1.91M	Price	164.26
IPO	May 02, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.34% 2.81%	Trades		Volume	2,150,879	Change	-0.73%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-14-25	Upgrade	Oppenheimer	Perform → Outperform	$180
Oct-03-25	Initiated	BMO Capital Markets	Market Perform	$156
Jul-28-25	Initiated	Raymond James	Mkt Perform
May-15-25	Downgrade	Oppenheimer	Outperform → Perform
Apr-16-25	Upgrade	Oppenheimer	Perform → Outperform	$159
Apr-08-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$165
Jan-27-25	Resumed	Barclays	Overweight	$224
Dec-20-24	Upgrade	Keefe Bruyette	Mkt Perform → Outperform	$166 → $202
Dec-12-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$212
Sep-12-24	Initiated	Wells Fargo	Equal Weight	$156
Aug-27-24	Initiated	Redburn Atlantic	Neutral	$140
Jun-13-24	Downgrade	Deutsche Bank	Buy → Hold	$176 → $132
May-28-24	Initiated	Deutsche Bank	Buy	$176
May-07-24	Initiated	TD Cowen	Buy	$154
Jan-09-24	Downgrade	Jefferies	Buy → Hold	$122
Oct-05-23	Initiated	Wolfe Research	Outperform	$133
Jul-10-23	Downgrade	Keefe Bruyette	Outperform → Mkt Perform	$99 → $98
Jun-12-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$99 → $93
Nov-14-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$93
Aug-31-22	Initiated	Barclays	Overweight	$92

Show Previous Ratings

Today 10:44AM	Goldman Sachs Adds Red-Hot Gaming and Technology Stocks to December Conviction List (24/7 Wall St.)
Dec-05-25 05:53PM	Carvana, CRH, and Comfort Systems USA to Join S&P 500 (Barrons.com)
04:34PM	The S&P 500 Is Due to Rebalance on Friday. What Could Change. (Barrons.com)
06:30AM	Wall Street Races to Cut Its Risk From AIs Borrowing Binge (Bloomberg)
01:00AM	The New Private-Equity Billionaires Who Are Taking Over Wall Street (Barrons.com)
08:05AM	Loading…
Dec-03-25 08:05AM	MGT and Ares Management Combine Forces to Create First Unicorn in SLED Services Industry (PR Newswire)
02:30AM	This Private-Credit Stock Has Gotten Hit Hard. Why It Still Might Join the S&P 500. (Barrons.com)
Dec-02-25 08:55AM	Inside Alts: Top investors weigh private options as public markets shrink (CNBC TV)
Dec-01-25 06:35PM	Analyst Report: Ares Management Corporation (Morningstar Research)
05:09PM	These Stocks Could Join the S&P 500 in Rebalancing (Barrons.com)
03:47PM	CRH, Vertiv, Ares, Alnylam Could Be Added to S&P 500 Friday in Rebalancing (Barrons.com)
06:00AM	Ares Management Introduces Marq to Further Unify its Global Logistics Platform Within its Real Estate Business (Business Wire)
Nov-27-25 10:31PM	Billions Down The Toilet As Private Equity Firms Take Bath On Hot New 'Continuation Vehicle' Strategy (Benzinga)
Nov-25-25 04:30PM	Ares Management Corporation to Present at the 2025 Goldman Sachs Financial Services Conference (ACCESSWIRE)
Nov-24-25 01:55PM	X-energy rides nuclear wave, raises $700M Series D (TechCrunch)
11:40AM	Loading…
11:40AM	AMG vs. ARES: Which Stock Is the Better Value Option? (Zacks)
Nov-20-25 11:42AM	How Blue Owl found itself at the middle of Wall Street's latest private credit fears (Yahoo Finance)
Nov-19-25 06:30AM	JPMorgans Super-Sized Checks Are Blowing Away All Other Lenders (Bloomberg)
Nov-15-25 12:03AM	Analyst Report: Ares Management Corporation (Morningstar Research)
Nov-14-25 07:48PM	The Evolution of Alpha (CNBC TV)
Nov-11-25 11:28AM	Banks just sent this upbeat signal about the economy. Here's why investors aren't buying it. (MarketWatch)
Nov-10-25 11:25AM	Apollo Buys Atlético Madrid for $2.55 Billion (Sportico)
05:16AM	Could Buying Ares Capital Stock Today Set You Up for Life? (Motley Fool)
12:30AM	5 Must-Read Analyst Questions From Ares's Q3 Earnings Call (StockStory)
Nov-06-25 04:00AM	TalkTalk forced to borrow to pay its bills as losses double (The Telegraph)
Nov-05-25 05:00PM	Ares Management Corporation to Present at the Citizens Financial Services Conference (ACCESSWIRE)
12:05PM	JPMorgans Billionaire Clients Want Sports Teams More Than Fine Art (Bloomberg)
05:32AM	Ares Management Completes Investment in Plenitude (Business Wire)
Nov-04-25 06:43PM	Private-Credit Earnings Ease Investor Concern Over Asset Classs Health (The Wall Street Journal)
04:40PM	Private-Credit Earnings Ease Investor Concern Over Market's Health (The Wall Street Journal)
12:32AM	Loading…
12:32AM	ARES Q3 Deep Dive: Diversified Fundraising and Broad-Based Deployment Drive Earnings Upside (StockStory)
Nov-03-25 01:05PM	Ares Management CEO: 'The wheels are in motion' to bring private investments into 401(k)s (CNBC TV)
06:30AM	Ares Management Announces Third Quarter 2025 U.S. Direct Lending Origination Activity (ACCESSWIRE)
06:19AM	Ares Management: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Ares Management Corporation Reports Third Quarter 2025 Results (Business Wire)
Nov-02-25 07:40AM	Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week (Yahoo Finance)
Nov-01-25 11:02PM	What To Expect From Ares's (ARES) Q3 Earnings (StockStory)
02:00PM	The Ranks of Corporate Zombies Are Growing: Credit Weekly (Bloomberg)
Oct-31-25 12:05PM	AMP vs. ARES: Which Stock Is the Better Value Option? (Zacks)
09:16AM	Ares Management Corp (ARES) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-30-25 04:18AM	Ares Management to Acquire BlueCove (Business Wire)
Oct-29-25 11:28AM	Liquid Credits Woes Are Good for Private Lenders, Ares Says (Bloomberg)
09:15AM	Ares Management (ARES) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
06:30AM	Ares Direct Lending Raises $1.5 Billion for Specialty Healthcare Strategy (Business Wire)
Oct-28-25 10:00AM	TPG Inc. (TPG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:00AM	Ares Capital Corporation Announces September 30, 2025 Financial Results and Declares Fourth Quarter 2025 Dividend of $0.48 Per Share (Business Wire)
05:30AM	Private Lenders Aren't Out of the Doghouse Yet (The Wall Street Journal)
04:15AM	Ares Management and Slate Asset Management to Acquire Polish Real Estate Portfolio Valued at Over 300 Million From Trei Real Estate (Business Wire)
Oct-27-25 10:00AM	Ares Management (ARES) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-24-25 10:35AM	Private-Asset Star Blue Owl Has Been Flying High. Is It Too Close to the Sun? (Barrons.com)
Oct-22-25 01:58PM	GreenBarn Investment Group and Sabal Investment Holdings Lead Refinancing of 817 Broadway in Manhattan (PR Newswire)
Oct-20-25 03:47PM	Credit Fears Make These Alternative Asset Manager Stocks a Buy, Goldman Says (Barrons.com)
06:30AM	Ares Management Appoints Bill Benjamin to Vice Chairman Role (Business Wire)
Oct-17-25 04:50PM	LenderMAC Enters into Strategic Relationship with Ares to Expand Origination and Non-QM Capabilities (PR Newswire)
Oct-15-25 11:31PM	Asset Management Stocks Q2 Teardown: Ares (NYSE:ARES) Vs The Rest (StockStory) -6.52%
08:02PM	Banks and Private Credit Clash After Dimons Cockroach Barb (Bloomberg)
03:26PM	The Alt-Manager Selloff Makes Ares Stock a Buy, This Analyst Says (Barrons.com)
09:00AM	Leading Asset Managers Launch Promote Giving, a Groundbreaking Model for Philanthropy Within the Investment Industry (Business Wire)
08:06AM	Ares Management (ARES) Soars 4.1%: Is Further Upside Left in the Stock? (Zacks)
08:01AM	How Promote Giving, a new investment model, will raise millions for charities (Associated Press Finance)
Oct-14-25 01:05PM	Ares (ARES) Stock Is Up, What You Need To Know (StockStory)
10:56AM	Financials Take Center Stage After Bank Earnings. 3 Stocks With Bullish Charts (Barrons.com)
Oct-11-25 02:30AM	Investors Keep Pumping Money into Private Credit, Despite Red Flags (Barrons.com)
Oct-10-25 03:57PM	BDCs Yield 10% or More. They May Be Worth the Risk. (Barrons.com)
Oct-09-25 03:55PM	Ares Management CEO on the value proposition of alternative assets (CNBC TV)
Oct-08-25 10:06AM	Wall Street Pours Billions Into Ares' $5.3B Infrastructure Bet (GuruFocus.com)
06:30AM	Ares Management Raises $5.3 Billion for Infrastructure Secondaries Strategy (Business Wire)
12:01AM	3 Big Reasons to Love Ares (ARES) (StockStory)
Oct-07-25 10:15AM	Ares' deVeer on AI Data Center Boom, Inflation Concerns (Bloomberg)
07:01AM	Ares Management secures 49% ownership in energy portfolio from EDPR (Power Technology)
Oct-06-25 06:29PM	Qualtrics to buy healthcare tech firm Press Ganey in $6.75 billion deal (Reuters)
08:57AM	Qualtrics to buy healthcare tech firm Press Ganey in $6.75 billion deal, FT reports (Reuters)
08:05AM	Ares Management Snags $2.9 Billion Stake In US Renewable Energy Portfolio (Benzinga)
06:30AM	Ares Management Acquires Stake in Diversified U.S. Energy Portfolio from EDPR (Business Wire)
Oct-03-25 06:00AM	Ares Management Corporation Schedules Earnings Release and Conference Call for the Third Quarter Ending September 30, 2025 (ACCESSWIRE)
Oct-01-25 07:05PM	TD Cowen Reaffirms Its Buy Rating on Ares Management Corporation (ARES) with $205 Price Target (Insider Monkey)
Sep-30-25 01:55PM	Ares Management to Buy Minority Stake in EP Wealth (Barrons.com)
09:00AM	Ares Management Buys Minority Stake in $40B EP Wealth (Wealth Management)
07:37AM	After a Trump Order, Private-Markets Managers Blackstone and Ares Get Set to Woo Small Investors (Barrons.com)
Sep-29-25 04:24PM	After a Trump Order, Private-Markets Managers Blackstone and Ares Get Set to Woo Small Investors (Barrons.com)
11:40AM	AMP vs. ARES: Which Stock Should Value Investors Buy Now? (Zacks)
06:30AM	Ares Management Acquires Meade Pipeline to Enhance Energy Infrastructure Portfolio (Business Wire)
03:28AM	Private Credit Gears Up for Biggest Year in Emerging Markets (Bloomberg)
Sep-27-25 02:30AM	A 'Transformational Shift' in Alts Is Underway. What Ares' CEO Sees for Its Future. (Barrons.com)
Sep-26-25 04:49PM	Ares Raises the Stakes With $8 Billion Data Center Bet (GuruFocus.com)
01:20PM	As Robotruck Maker Kodiak Robotics Starts Trading, Should You Buy KDK Stock? (Barchart)
Sep-24-25 04:05PM	Autonomous Truck Startup Kodiak Set to Go Public After $2.5 Billion Deal (The Wall Street Journal) -7.13%
Sep-23-25 10:21AM	Atletico owners negotiating with US firm Apollo over majority stake sale - reports (AFP)
Sep-22-25 09:34PM	Ex-BlackRock Executive Seeks $700 Million for Credit Hedge Fund (Bloomberg)
Sep-19-25 12:11PM	Carlyle Turnaround Halts $1T Merger Talks With Macquarie Group (Zacks)
Sep-09-25 07:01AM	Wall Street Titans Just Dropped $3.9 Billion on This Home Services Empire--Here's Why (GuruFocus.com)
Sep-08-25 11:42AM	Leaf Home Announces Acquisition of Erie Home, Uniting Two Leading Residential Services Providers (PR Newswire)
Sep-06-25 01:13AM	Ares Management Expands in Australia with New Infrastructure Fund (Insider Monkey)
Sep-04-25 04:17PM	Ares CEO Arougheti Sees PE and Sports Investing Colliding (Bloomberg)
Sep-03-25 08:07AM	ID.me tops $2 billion valuation in latest fundraise amid push to combat AI-driven fraud (Reuters)
06:30AM	Ares Management Appoints Anup Agarwal as Head and Chief Investment Officer of Ares Insurance Solutions (Business Wire)
Sep-02-25 05:15PM	Ares Capital Corporation Prices Public Offering of $650 Million 5.100% Unsecured Notes Due 2031 (Business Wire)
06:30AM	Ares Acquisition Corporation II and Kodiak Robotics, Inc. Announce Effectiveness of Registration Statement and September 23, 2025 Extraordinary General Meeting to Approve Business Combination (Business Wire)
Aug-28-25 05:00PM	Ares Management Corporation to Present at the Barclays Global Financial Services Conference (ACCESSWIRE)
Aug-22-25 12:13PM	Private Equity Is Headed for Your 401(k). The Industry Is Celebrating. Should You? (Barrons.com)

Ares Management Corp. engages in the provision of investment and consultancy services. It operates through the following segments: Credit Group, Private Equity Group, Real Assets Group, Secondaries Group, and Other. The Credit Group segment includes the management of strategies across the liquid and illiquid spectrum, direct lending, and Asia-Pacific. The Private Equity Group segment involves the categorization of investment strategies as corporate, special opportunities, and Asia-Pacific. The Real Assets Group segment focuses on equity and debt strategies across infrastructure investments. The Secondaries Group segment consists of investment in secondary markets, alternative asset class strategies, private equity, real estate, infrastructure, and credit. The company was founded by Michael J. Arougheti, David B. Kaplan, John H. Kissick, Antony P. Ressler, and Bennett Rosenthal in 1997 and is headquartered in Los Angeles, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Arougheti Michael J	Co-Founder and CEO	Nov 26 '25	Sale	154.48	136,067	21,019,622	154,930	Dec 01 08:57 PM
Arougheti Michael J	Co-Founder and CEO	Nov 28 '25	Sale	156.15	98,673	15,408,069	56,257	Dec 01 08:57 PM
Arougheti Michael J	Co-Founder and CEO	Dec 01 '25	Sale	157.26	56,257	8,847,108	0	Dec 01 08:57 PM
Arougheti Michael J	Co-Founder and CEO	Nov 25 '25	Sale	152.75	186,197	28,442,509	290,997	Nov 25 09:15 PM
Arougheti Michael J	Co-Founder and CEO	Nov 24 '25	Sale	150.15	112,806	16,937,821	477,194	Nov 25 09:15 PM
ATTICUS ENTERPRISES LLC	Director	Nov 24 '25	Proposed Sale	147.43	590,000	86,983,700		Nov 24 04:27 PM
Sagati Aghili Naseem	General Counsel	Oct 01 '25	Sale	155.97	21,000	3,275,370	255,397	Oct 03 08:38 PM
NASEEM SAGATI AGHILI	Officer	Oct 01 '25	Proposed Sale	159.89	21,000	3,357,690		Oct 01 04:37 PM
Sagati Aghili Naseem	General Counsel	Sep 10 '25	Sale	178.40	21,000	3,746,321	276,397	Sep 12 07:34 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 10 '25	Sale	178.30	128,837	22,971,970	0	Sep 12 07:33 PM
ARES MANAGEMENT LLC	10% Owner	Sep 10 '25	Sale	1.13	13,000,000	14,710,800	41,197,491	Sep 11 04:31 PM
ARES MANAGEMENT LLC	10% Owner	Sep 09 '25	Sale	1.39	1,631,555	2,261,335	54,197,491	Sep 11 04:31 PM
TJ CAPITAL INVESTORS LLC	Director	Sep 10 '25	Proposed Sale	175.07	128,837	22,555,494		Sep 10 04:40 PM
NASEEM SAGATI AGHILI	Officer	Sep 10 '25	Proposed Sale	175.07	21,000	3,676,470		Sep 10 04:38 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 08 '25	Sale	175.78	170,341	29,942,945	230,237	Sep 09 09:42 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 09 '25	Sale	175.53	101,400	17,799,237	128,837	Sep 09 09:42 PM
TJ CAPITAL INVESTORS LLC	Director	Sep 09 '25	Proposed Sale	176.25	95,701	16,867,301		Sep 09 04:30 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 05 '25	Sale	177.05	176,784	31,300,367	400,578	Sep 05 08:37 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 04 '25	Sale	179.05	161,656	28,945,033	577,362	Sep 05 08:37 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 03 '25	Sale	176.76	126,499	22,359,617	739,018	Sep 05 08:37 PM
TJ CAPITAL INVESTORS LLC	Director	Sep 05 '25	Proposed Sale	180.05	300,000	54,015,000		Sep 05 04:38 PM
TJ CAPITAL INVESTORS LLC	Director	Sep 03 '25	Proposed Sale	179.78	300,000	53,934,000		Sep 03 04:33 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 02 '25	Sale	178.61	177,929	31,780,770	865,517	Sep 02 08:27 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 29 '25	Sale	179.30	101,032	18,115,234	1,043,446	Sep 02 08:27 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 29 '25	Proposed Sale	180.27	300,000	54,081,000		Aug 29 04:17 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 27 '25	Sale	180.23	171,686	30,943,111	1,252,852	Aug 28 08:05 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 28 '25	Sale	180.72	108,374	19,585,265	1,144,478	Aug 28 08:05 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 27 '25	Proposed Sale	178.93	300,000	53,679,000		Aug 27 04:29 PM
Arougheti Michael J	Co-Founder and CEO	Aug 25 '25	Sale	178.19	44,760	7,975,789	0	Aug 26 09:39 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 26 '25	Sale	178.79	196,197	35,077,536	1,424,538	Aug 26 09:38 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 25 '25	Sale	178.08	112,522	20,037,464	1,620,735	Aug 26 09:38 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 26 '25	Proposed Sale	178.13	196,197	34,948,572		Aug 26 04:26 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 25 '25	Proposed Sale	181.07	112,522	20,374,359		Aug 25 04:38 PM
Arougheti Michael J	Co-Founder and CEO	Aug 22 '25	Sale	181.65	105,648	19,191,285	44,760	Aug 22 09:28 PM
Arougheti Michael J	Co-Founder and CEO	Aug 20 '25	Sale	178.39	97,880	17,461,120	213,848	Aug 22 09:28 PM
Arougheti Michael J	Co-Founder and CEO	Aug 21 '25	Sale	178.20	63,440	11,304,739	150,408	Aug 22 09:28 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 22 '25	Sale	181.65	105,394	19,144,739	1,733,257	Aug 22 09:28 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 20 '25	Sale	178.40	97,971	17,477,619	1,902,029	Aug 22 09:28 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 21 '25	Sale	178.19	63,378	11,293,585	1,838,651	Aug 22 09:28 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 20 '25	Proposed Sale	180.59	300,000	54,177,000		Aug 20 04:21 PM
Arougheti Michael J	Co-Founder and CEO	Aug 19 '25	Sale	182.74	136,516	24,946,638	311,728	Aug 19 08:49 PM
Arougheti Michael J	Co-Founder and CEO	Aug 18 '25	Sale	189.05	85,552	16,173,525	448,244	Aug 19 08:49 PM
Arougheti Michael J	Co-Founder and CEO	Aug 15 '25	Sale	188.69	56,204	10,604,893	533,796	Aug 19 08:49 PM
ATTICUS ENTERPRISES LLC	Director	Aug 18 '25	Proposed Sale	187.78	533,796	100,236,213		Aug 18 04:42 PM
ATTICUS ENTERPRISES LLC	Director	Aug 15 '25	Proposed Sale	190.45	56,204	10,704,052		Aug 15 04:24 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	Jun 12 '25	Sale	168.79	85,000	14,347,484	0	Jun 13 07:54 PM
ARES MANAGEMENT LLC	10% Owner	Jun 11 '25	Sale	8.86	2,250,000	19,928,025	117,449,188	Jun 13 04:32 PM
BAR HOLDINGS, LLC	Director	Jun 12 '25	Proposed Sale	168.78	85,000	14,346,300		Jun 12 04:20 PM
KAPLAN DAVID B	Co-Founder	May 30 '25	Sale	165.12	33,145	5,472,902	0	Jun 03 06:37 PM
KAPLAN DAVID B	Co-Founder	May 29 '25	Sale	165.06	23,524	3,882,871	33,145	May 29 08:59 PM
KAPLAN DAVID B	Co-Founder	May 28 '25	Sale	165.06	5,205	859,137	56,669	May 29 08:59 PM
KAPLAN DAVID B	Co-Founder	May 27 '25	Sale	165.07	626	103,334	61,874	May 29 08:59 PM
TRENTLY HOLDINGS, LLC	Officer	May 27 '25	Proposed Sale	160.29	62,500	10,018,125		May 27 04:32 PM
Arougheti Michael J	Co-Founder and CEO	May 20 '25	Sale	166.37	150,000	24,955,537	107,500	May 22 06:41 PM
Arougheti Michael J	Co-Founder and CEO	May 21 '25	Sale	161.34	107,500	17,344,225	0	May 22 06:41 PM
ARES MANAGEMENT LLC	10% Owner	May 16 '25	Sale	8.86	14,960,000	132,499,224	119,699,188	May 20 04:31 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	May 15 '25	Sale	169.37	40,000	6,774,878	85,000	May 19 08:18 PM
KAPLAN DAVID B	Co-Founder	May 15 '25	Sale	169.36	62,500	10,584,827	62,500	May 19 08:18 PM
Arougheti Michael J	Co-Founder and CEO	May 16 '25	Sale	170.07	182,108	30,971,183	350,684	May 19 08:17 PM
Arougheti Michael J	Co-Founder and CEO	May 19 '25	Sale	168.87	93,184	15,735,584	257,500	May 19 08:17 PM
Arougheti Michael J	Co-Founder and CEO	May 15 '25	Sale	169.55	57,208	9,699,584	532,792	May 19 08:17 PM
BAR HOLDINGS, LLC	Officer	May 15 '25	Proposed Sale	175.83	40,000	7,033,200		May 15 04:24 PM
TRENTLY HOLDINGS, LLC	Officer	May 15 '25	Proposed Sale	175.83	62,500	10,989,375		May 15 04:23 PM
ATTICUS ENTERPRISES LLC	Director	May 15 '25	Proposed Sale	175.83	590,000	103,739,700		May 15 04:22 PM
Arougheti Michael J	Co-Founder and CEO	Mar 24 '25	Sale	153.17	110,845	16,977,649	1,400,000	Mar 26 05:58 PM
MICHAEL J AROUGHETI	Officer	Mar 24 '25	Proposed Sale	147.71	110,845	16,372,915		Mar 24 04:22 PM
BHUTANI ASHISH	Director	Mar 11 '25	Buy	141.33	10,000	1,413,300	22,905	Mar 13 08:14 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	Mar 04 '25	Sale	161.01	69,809	11,239,742	30,191	Mar 06 09:06 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	Mar 05 '25	Sale	160.99	30,191	4,860,362	0	Mar 06 09:06 PM
KAPLAN DAVID B	Co-Founder	Mar 04 '25	Sale	160.99	69,526	11,192,960	30,474	Mar 06 08:57 PM
KAPLAN DAVID B	Co-Founder	Mar 05 '25	Sale	160.99	30,474	4,906,037	0	Mar 06 08:57 PM
TRENTLY HOLDINGS	Officer	Mar 04 '25	Proposed Sale	169.76	100,000	16,976,000		Mar 04 05:10 PM
BAR HOLDINGS, LLC	Officer	Mar 04 '25	Proposed Sale	169.76	100,000	16,976,000		Mar 04 05:10 PM
deVeer R. Kipp	Co-President	Feb 06 '25	Sale	190.02	78,933	14,998,894	1,150,000	Feb 10 08:01 PM
ROBERT KIPP DEVEER	Officer	Feb 06 '25	Proposed Sale	189.65	78,933	14,969,643		Feb 06 04:22 PM
Berry Ryan	Chief Mktg. & Strategy Officer	Dec 11 '24	Sale	180.16	14,357	2,586,557	233,214	Dec 13 08:10 PM
ARES MANAGEMENT LLC	10% Owner	Dec 10 '24	Sale	34.37	11,500,000	395,255,000	23,922,768	Dec 12 04:17 PM
Berry Ryan	Chief Mktg. & Strategy Officer	Dec 09 '24	Sale	180.14	5,443	980,502	247,771	Dec 10 09:14 PM
deVeer R. Kipp	Head of Credit Group	Dec 09 '24	Sale	176.82	121,762	21,529,463	1,137,400	Dec 10 09:13 PM
deVeer R. Kipp	Head of Credit Group	Dec 10 '24	Sale	176.57	62,400	11,017,852	1,075,000	Dec 10 09:13 PM
ARES MANAGEMENT LLC	10% Owner	Dec 09 '24	Sale	34.61	300,000	10,384,440	35,422,768	Dec 10 04:32 PM
ROBERT KIPP DEVEER	Officer	Dec 10 '24	Proposed Sale	175.29	62,400	10,938,096		Dec 10 04:28 PM
ROBERT KIPP DEVEER	Officer	Dec 09 '24	Proposed Sale	178.07	121,762	21,682,159		Dec 09 04:49 PM

UTHR

United Therapeutics Corp

ARES

Ares Management Corp

Upgrade your FINVIZ experience